Helminth-derived Immunomodulatory Glycan LNFP Ⅲ Impairs Pathogenesis of Peripheral Neuropathic Pain and Spinal Glial Activation

DING You-quan, REN Hong-yi, XIAO Xia. et al

Abstract

To investigate the effect of helminth-derived immunomodulatory glycan lacto-N-fucopentaose Ⅲ（LNFPⅢ） on the pathogenesis of neuropathic pain and spinal glial activation in the corresponding time windows after adult rat tibial nerve permanent transection (modified spared nerve injury, mSNI). Methods Ten weeks old male adult Sprague-Dawley (SD) rats weighing 250-300 g were randomly grouped into four groups: sham-operated group (n =6), mSNI group (n =6), mSNI plus bovine serum albumin (BSA) group (n =12) and mSNI plus LNFPⅢ group (n =12). Rats were subjected to surgical operation or sham operation on the right tibial nerves and were intraperitoneal injected BSA or LNEPⅢ-BSA conjugates by the group design. Animals from each group (n =6 per group) were subjected to the plantar test, von Frey hairs test, pinprick test and acetone test for critical evaluation of region-specific pain responses on the plantar sural and saphenous skin territories of ipsilateral and contralateral hindpaws after injuries. Transverse frozen sections of L3-4 spinal cords from the remaining animals of mSNI plus BSA group and mSNI plus LNFPⅢ group 7 and 14 d after injury (n =3 for each time point per group) were prepared and subjected to immunofluorescent staining of microglia/macrophage marker 〔cluster of differentiation molecule 11b (CD11b)〕 and astrocyte marker 〔glial fibrillary acidic protein (GFAP)〕, for analysis of spinal glial activation. Results After adult rat mSNI, early systematic administration of LNFPⅢ significantly but not completely attenuated region-specific pathological pain evoked by mechanical and thermal stimuli on the sural and saphenous skin territories of rat hindpaw plantar surfaces in acute (4/5 d after injuries) and subacute (7/8 d and 14/15 d after injuries) phases. Meanwhile, in the ipsilateral spinal cord dorsal horns, this early systematic treatment inhibited microglia/macrophage activation 7 d after injury and astrocyte activation 7 and 14 d after injury. Conclusion Early systematic administration of LNFPⅢ impairs the pathogenesis (acute induction and chronic transition) of neuropathic pain and spinal glial activation in the corresponding time windows after adult rat mSNI.

 

Keywords: Peripheral nerves, Neuroglial cells, Neuropathic pain, LNFPⅢ 

 

Full Text:

PDF


References


SCHOLZJ, WOOLF CJ. The neuropathic pain triad; neurons, immune cells and glia. Nat Neurosci,2007, 10( 11): 1361-1368.

GRACE PM. ROLAN PE. HUTCHINSON MR. Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain. Brain Behav Immun. 2011.25(7):1322-1332.

ZHANG J. SHI XQ. ECHEVERRY S. et al. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci. 2007.27 (45):12396-12406.

JI RR. SUTER MR. p38 МАРК, microglial signaling, and neuropathic pain. Mol Pain,2007(3) ;33.

AUSTIN PJ. MOALEM-TAYLOR G. The neuro-immune balance in neuropathic pain; involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol.2010,229(1/2);26-50.

ZHANG X, WU Z, HAYASHI Y, et al. Peripheral role of cathepsin S in Thl cell-dependent transition of nerve injury- induced acute pain to a chronic pain state. J Neurosci,2014, 34(8):3013-3022.

CAO L, PALMER CD, MALON JT, et al. Critical role of microglial CD40 in the maintenance of mechanical hypersensitivity in a murine model of neuropathic pain. Eur J Immunol,2009.39( 12):3562-3569.

GAO YJ, JI RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics,2010,7(4):482-493.

WAMMES LJ, MPAIRWE H. ELLIOTT AM, et al. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. Lancet Infect Dis.2014,14(11);1150-1162.

HARNETT W, HARNETT MM. Helminth-derived immunomodulators:can understanding the worm produce the pill? Nat Rev Immunol. 2010,10( 4 ); 278-284.

LUNDY SK, LUKACS NW. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front Immunol. 2013(4 ): 39 2013-02- 20]. http: / / www. ncbi. nlm. nih. gov/pmc/articles/ РМС3576626/. doi; 10. 3389/fimmu. 2013. 00039. BHARGAVA P. LI C ST ANYA KJ. et al. Immunomodulatory glycan LNFPHI alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med,2012,18(11); 1665-1672.

LEEBH, WON R. В AIK EJ, et al. An animal model of neuropathic pain employing injury to the sciatic nerve branches. Neuroreport,2000,11(4) :657-661.

HOFMANN HA, DE VRY J, SIEGLING A, et al. Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain. Eur J Pharmacol, 2003,470( 1/2): 17-25.

COBIANCHI S, DE CRUZ J, NAVARRO X. Assessment of sensory thresholds and nociceptive fiber growth after sciatic nerve injury reveals the differential contribution of collateral reinnervation and nerve regeneration to neuropathic pain. Exp Neurol, 2014 ( 255) ; 1-11 [2014-02-16]. http://www. sciencedirect. com,/ science/article/pii/SOO 144 88614000533.doi; 10. 1016/j. expneurol. 2014. 02. 008.

REN HY, DING YQ, XIAO X, et al. Behavioral characterization of neuropathic pain on the glabrous skin areas reinnervated solely by axotomy-regenerative axons after adult rat sciatic nerve crush. Neuroreport,2016 ,27(6) :404-414.

ATOCHINA О, HARN D. LNFP LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol. 2005, 12 ( 9 ); 1041- 1049.


Refbacks

  • There are currently no refbacks.